Jitendra Kanodia

914 total citations
32 papers, 639 citations indexed

About

Jitendra Kanodia is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jitendra Kanodia has authored 32 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Jitendra Kanodia's work include Developmental Biology and Gene Regulation (6 papers), CAR-T cell therapy research (5 papers) and Cardiovascular Syncope and Autonomic Disorders (3 papers). Jitendra Kanodia is often cited by papers focused on Developmental Biology and Gene Regulation (6 papers), CAR-T cell therapy research (5 papers) and Cardiovascular Syncope and Autonomic Disorders (3 papers). Jitendra Kanodia collaborates with scholars based in United States, France and Sweden. Jitendra Kanodia's co-authors include Stanislav Y. Shvartsman, Yoosik Kim, Hang Lu, Kwanghun Chung, Sirish L. Shah, Arun K. Tangirala, Richa Rikhy, Jennifer Lippincott‐Schwartz, Robert DeLotto and Viktor K. Lund and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jitendra Kanodia

27 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jitendra Kanodia United States 15 354 101 101 78 52 32 639
Michael Pargett United States 15 482 1.4× 52 0.5× 109 1.1× 51 0.7× 66 1.3× 27 654
Toshio Yoshizawa Japan 16 386 1.1× 60 0.6× 387 3.8× 108 1.4× 73 1.4× 59 943
Brian Loranger United Kingdom 5 373 1.1× 84 0.8× 80 0.8× 52 0.7× 32 0.6× 9 734
Anand R. Asthagiri United States 17 500 1.4× 242 2.4× 353 3.5× 47 0.6× 106 2.0× 33 932
Yiyong Liu United States 21 996 2.8× 110 1.1× 108 1.1× 38 0.5× 220 4.2× 49 1.4k
Ali Sharifi‐Zarchi Iran 17 542 1.5× 83 0.8× 30 0.3× 20 0.3× 35 0.7× 51 809
Satoshi Komatsu Japan 18 625 1.8× 111 1.1× 304 3.0× 59 0.8× 33 0.6× 79 1.1k
Marko Ušaj Sweden 15 316 0.9× 234 2.3× 55 0.5× 59 0.8× 13 0.3× 30 628

Countries citing papers authored by Jitendra Kanodia

Since Specialization
Citations

This map shows the geographic impact of Jitendra Kanodia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jitendra Kanodia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jitendra Kanodia more than expected).

Fields of papers citing papers by Jitendra Kanodia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jitendra Kanodia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jitendra Kanodia. The network helps show where Jitendra Kanodia may publish in the future.

Co-authorship network of co-authors of Jitendra Kanodia

This figure shows the co-authorship network connecting the top 25 collaborators of Jitendra Kanodia. A scholar is included among the top collaborators of Jitendra Kanodia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jitendra Kanodia. Jitendra Kanodia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hung, Kenneth E., S. Aggarwal, Sharron Gargosky, et al.. (2025). P1097 Phase 1/2 study to assess safety, tolerability, and efficacy of XmAb942 (anti-TL1A) in healthy participants and participants with ulcerative colitis. Journal of Crohn s and Colitis. 19(Supplement_1). i2015–i2015.
3.
Younis, Islam R., et al.. (2024). An IQ Industry Perspective on Informing Dosing Recommendations in Patients With Renal Impairment. Clinical Pharmacology & Therapeutics. 117(2). 337–342.
4.
Kanodia, Jitendra, Hugh Giovinazzo, David L. Bourdet, et al.. (2024). Hepatic Dysfunction Quantified by HepQuant DuO Outperforms Child‐Pugh Classification in Predicting the Pharmacokinetics of Ampreloxetine. Clinical Pharmacology & Therapeutics. 116(1). 186–193. 2 indexed citations
5.
Riedell, Peter A., Krish Patel, Yasmin Karimi, et al.. (2024). Plamotamab: First Presentation of Subcutaneous Administration in a Phase 1 Dose Escalation Study in Heavily Pretreated R/R NHL Patients Who Had Prior CAR-T Cell Therapy. Blood. 144(Supplement 1). 4497–4497. 2 indexed citations
6.
Pruimboom‐Brees, Ingrid, Swati Gupta, Nagendra Chemuturi, et al.. (2023). International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs. Clinical and Translational Science. 16(5). 723–741. 6 indexed citations
7.
Bupathi, Manojkumar, Siwen Hu‐Lieskovan, Sarina A. Piha‐Paul, et al.. (2023). 764 A phase 1, first-in-human (FIH), open-label, dose-finding and expansion study of XmAb808, a B7H3 x CD28 bispecific antibody, in combination with pembrolizumab in patients with advanced solid tumors. SHILAP Revista de lepidopterología. A859–A859. 3 indexed citations
8.
9.
Ravandi, Farhad, Asad Bashey, James M. Foran, et al.. (2023). Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia. Blood Advances. 7(21). 6492–6505. 24 indexed citations
10.
Maher, Jonathan, Rui Zhang, Gopinath S. Palanisamy, et al.. (2022). Lung-restricted ALK5 inhibition avoids systemic toxicities associated with TGFβ pathway inhibition. Toxicology and Applied Pharmacology. 438. 115905–115905. 7 indexed citations
11.
Lo, Arthur, Lucy Norcliffe‐Kaufmann, Ross G. Vickery, David L. Bourdet, & Jitendra Kanodia. (2021). Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension. Clinical Autonomic Research. 31(3). 395–403. 6 indexed citations
12.
Kaufmann, Horacio, Ross G. Vickery, Whedy Wang, et al.. (2021). Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. Clinical Autonomic Research. 31(6). 699–711. 16 indexed citations
13.
Kanodia, Jitendra, Arthur Lo, R. Michael Baldwin, Richard Graham, & David L. Bourdet. (2020). Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain. Clinical Pharmacokinetics. 60(1). 121–131. 4 indexed citations
14.
Tom, Irene, Victoria C. Pham, Kenneth J. Katschke, et al.. (2020). Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy. Proceedings of the National Academy of Sciences. 117(18). 9952–9963. 40 indexed citations
15.
Gadkar, Kapil, Daniela Bumbaca Yadav, Jessica A. Couch, et al.. (2016). Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain. European Journal of Pharmaceutics and Biopharmaceutics. 101. 53–61. 40 indexed citations
16.
Kanodia, Jitendra, Diana H. Chai, Jaeyeon Kim, et al.. (2014). Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles. Cell Communication and Signaling. 12(1). 34–34. 28 indexed citations
17.
Kanodia, Jitendra, et al.. (2012). Evolution of BMP Signaling in Drosophila Oogenesis: A Receptor-Based Mechanism. Biophysical Journal. 102(8). 1722–1730. 14 indexed citations
18.
Kavousanakis, Michail E., Jitendra Kanodia, Yoosik Kim, Ioannis G. Kevrekidis, & Stanislav Y. Shvartsman. (2010). A compartmental model for the bicoid gradient. Developmental Biology. 345(1). 12–17. 17 indexed citations
19.
Chung, Kwanghun, et al.. (2010). A microfluidic array for large-scale ordering and orientation of embryos. Nature Methods. 8(2). 171–176. 123 indexed citations
20.
Zartman, Jeremiah J., Jitendra Kanodia, Nir Yakoby, et al.. (2008). Expression patterns of cadherin genes in Drosophila oogenesis. Gene Expression Patterns. 9(1). 31–36. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Pargett Breakdown of academic impact, for papers by Toshio Yoshizawa Breakdown of academic impact, for papers by Brian Loranger Breakdown of academic impact, for papers by Anand R. Asthagiri Breakdown of academic impact, for papers by Yiyong Liu Breakdown of academic impact, for papers by Ali Sharifi‐Zarchi Breakdown of academic impact, for papers by Satoshi Komatsu Breakdown of academic impact, for papers by Marko Ušaj
Rankless by CCL
2026